Modern medicine tries to solve the problems of pain and inflammation symptomatic more than 100 rheumatic diseases with osteoarthritis and rheumatoid arthritis among others.
Statistically, 10-12% of the adult population is diagnosed with osteoarthritis. Among older people, the osteoarthritis statistics reaches 70-80%. Rheumatoid arthritis rarely strikes young people, but when it does there are many severe complications.
Arthritis has many unpleasant symptoms such as general weakness, painful and swollen joints, body stiffness in the morning, body aches, weight loss, and blood changes.
It’s known that it is very difficult to identify the symptoms of arthritis at an early stage of the disease. It is also virtually impossible to pinpoint the causes of rheumatoid arthritis. It is impossible to cure arthritis completely but it is possible to alleviate the symptoms and prevent further development of the disease. Modern medicine helps to reduce inflammation, improving the function of the joints. It helps patients to stay active. Early diagnosis and timely treatment improve positive prognosis.
The first in the line of defense from rheumatoid arthritis are effective and fast-acting anti-inflammatory drugs. Celecoxib belongs to selective non-steroidal anti-inflammatory drugs. It proved very effective in the treatment of rheumatoid arthritis. Even though it is very strong but it didn’t have many side effects associated with the long-term medication. Celebrex has Celecoxib as its main active ingredient.
As many other NSAIDs Celebrex is effective in the treatment of rheumatoid arthritis. However, unlike many other NSAIDs, there is fewer precautions and side effects. It is less likely to cause severe reactions, especially from the gastrointestinal tract. Celebrex can be taken for a long time: the treatment can last from several weeks to several months and even years.
Clinical trials showed that Celebrex has anti-inflammatory, antipyretic and analgesic effects. The clinical study “Success” was conducted in 600 clinical centers of more than 20 countries with the participation of 14 000 patients. The results of the study proved that within the first 24 hours Celebrex significantly reduces the severity of the arthritis pain in patients. Therapeutic effect of Celebrex didn’t go down for 24 weeks and even built up with duration of its use.
In terms of a number of the digestive system side effects, Celebrex was comparable to the result of patients in placebo group. It’s a better choice compared to Diclofenac with its high risk of causing adverse reactions.
At the Third Annual European Rheumatology Congress, a team of scientists from 10 leading Canadian medical centers presented a detailed meta-analysis of 456 scientific publications on the results of randomized clinical trials. The conclusion of the meta-analysis proves the high safety profile of Celebrex as an anti-inflammatory drug. Moreover, American scientists also conducted extensive studies to conclude Celebrex (not rofecoxib) does not cause an increased blood pressure in patients with osteoarthritis complicated with hypertension. It is seen as an important advantage of the drug.